Literature DB >> 30877003

Short-Term Spontaneous Resolution of Ruptured Peripheral Aneurysm in Moyamoya Disease.

Hiroki Yamada1, Isako Saga2, Atsuhiro Kojima2, Takashi Horiguchi3.   

Abstract

BACKGROUND: Peripheral aneurysms are known to be a source of intracranial hemorrhage in patients with moyamoya disease. However, the natural history of ruptured peripheral aneurysms remains unclear. Some regress spontaneously, whereas others may rebleed. Direct treatments, such as surgical or intravascular treatment of the peripheral aneurysm, can have a risk of severe neurologic complications owing to the depth of the operative field and the fragility of the parent artery. A careful treatment policy is required. CASE DESCRIPTION: In a 29-year-old man with moyamoya disease with intraventricular hemorrhage, rupture of a right anterior choroidal artery aneurysm was diagnosed by cerebral angiography. The aneurysm was approximately 4 mm in size and existed in the plexal segment of the right anterior choroidal artery. Endovascular embolization of the aneurysm was planned. However, repeat angiography 3 weeks after aneurysm diagnosis demonstrated complete resolution of the aneurysm. Such short-term disappearance of an aneurysm is remarkably rare. We believe that the aneurysm was thrombosed for a brief period considering the slow blood flow detected inside the aneurysm during the initial angiography. The patient was discharged with no neurologic deficit and has remained recurrence-free for >1 year.
CONCLUSIONS: Given that spontaneous resolution of an aneurysm may occur in a short period of time, we suggest that conservative treatment be considered as an option for ruptured peripheral aneurysms associated with moyamoya disease when direct treatment is risky.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Moyamoya disease; Ruptured aneurysm; Spontaneous resolution; Thrombosis

Mesh:

Year:  2019        PMID: 30877003     DOI: 10.1016/j.wneu.2019.02.193

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

1.  Location-based treatment of intracranial aneurysms in moyamoya disease: a systematic review and descriptive analysis.

Authors:  Anthony S Larson; Lorenzo Rinaldo; Waleed Brinjikji; Giuseppe Lanzino
Journal:  Neurosurg Rev       Date:  2020-05-08       Impact factor: 3.042

Review 2.  The prospects and pitfalls in the endovascular treatment of moyamoya disease-associated intracranial aneurysms.

Authors:  Kun Hou; Guichen Li; Tengfei Luan; Kan Xu; Jinlu Yu
Journal:  Neurosurg Rev       Date:  2020-02-12       Impact factor: 3.042

3.  Surgical revascularization vs. conservative treatment for adult hemorrhagic moyamoya disease: analysis of rebleeding in 322 consecutive patients.

Authors:  Shaojie Yu; Nan Zhang; Jian Liu; Changwen Li; Sheng Qian; Yong Xu; Tao Yang; Nan Li; Minghui Zeng; Dongxue Li; Chengyu Xia
Journal:  Neurosurg Rev       Date:  2021-12-03       Impact factor: 3.042

4.  Development and natural course of lateral posterior choroidal artery aneurysms arising from fragile choroidal collaterals in moyamoya disease: illustrative cases.

Authors:  Tomoaki Suzuki; Hitoshi Hasegawa; Kouichirou Okamoto; Kazuhiro Ando; Kohei Shibuya; Haruhiko Takahashi; Shoji Saito; Makoto Oishi; Yukihiko Fujii
Journal:  J Neurosurg Case Lessons       Date:  2021-04-12

5.  Transcallosal, transchoroidal clipping of a hypothalamic collateral vessel aneurysm in Moyamoya disease.

Authors:  Wing Mann Ho; Alice Stephanie Görke; Florian Dazinger; Bettina Pfausler; Elke R Gizewski; Ondra Petr; Claudius Thomé
Journal:  Acta Neurochir (Wien)       Date:  2020-04-19       Impact factor: 2.216

Review 6.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.